₹ 0.8 Cr
Volume Transacted
(Nov 8, 2024)
6.2 K
Stocks Traded
(Nov 8, 2024)
Last Updated on: Nov 08, 2024
Aurobindo Pharma Ltd
NSE: AUROPHARMA
YEARLOW
₹ 903.8
Last updated on: Nov 07, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
07 Nov 2024 | 1350.5 | 1399.7 | 1399.7 | 1346 |
06 Nov 2024 | 1394.65 | 1411 | 1411 | 1393 |
05 Nov 2024 | 1396.1 | 1414.6 | 1416.2 | 1360.45 |
04 Nov 2024 | 1407.25 | 1392.65 | 1410.85 | 1383.1 |
01 Nov 2024 | 1401.1 | 1396.05 | 1408 | 1395 |
31 Oct 2024 | 1396 | 1418.65 | 1420.15 | 1389.6 |
30 Oct 2024 | 1404.7 | 1401.65 | 1418.95 | 1384.25 |
29 Oct 2024 | 1412.65 | 1437.7 | 1437.7 | 1398.7 |
28 Oct 2024 | 1433.85 | 1401.05 | 1442.65 | 1401.05 |
25 Oct 2024 | 1427.15 | 1431.05 | 1455 | 1414.85 |
Date | Price (₹) |
---|---|
07 Nov 2024 | 1350.5 |
06 Nov 2024 | 1394.65 |
05 Nov 2024 | 1396.1 |
04 Nov 2024 | 1407.25 |
01 Nov 2024 | 1401.1 |
31 Oct 2024 | 1396 |
30 Oct 2024 | 1404.7 |
29 Oct 2024 | 1412.65 |
28 Oct 2024 | 1433.85 |
25 Oct 2024 | 1427.15 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Aurobindo Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Aurobindo Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Aurobindo Pharma to table results
Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 9 Novembe...
02 Nov 202412:52
Aurobindo Pharma completes acquisition of balance 49% stake in GLS Pharma
Aurobindo Pharma has completed the acquisition of balance 49% stake in its subsidiary, GLS...
25 Oct 202419:30
Aurobindo Pharma Ltd spurts 1.19%, up for fifth straight session
Aurobindo Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs...
09 Oct 202413:00
Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
Aurogen South Africa, (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma in...
05 Oct 202410:19
Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
Aurogen South Africa (Aurogen), a wholly owned step-down subsidiary of Aurobindo Pharma in...
05 Oct 202410:21
Auro Pharma gets USFDA nod for urinary tract infections drug.
The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...
03 Oct 202414:58
FAQs for 52 Week Low of Aurobindo Pharma Ltd
Why is it important to track the 52-week low of Aurobindo Pharma Ltd stocks?
What factors can lead to Aurobindo Pharma Ltd stocks hitting a 52-week low?
Should investors buy Aurobindo Pharma Ltd stocks when they hit a 52-week low?
How often should investors monitor the 52-week low of Aurobindo Pharma Ltd stocks?
How can an investor assess the risk of buying Aurobindo Pharma Ltd stock at their 52-week low?
Should investors consider the overall market trend when evaluating Aurobindo Pharma Ltd stocks at their 52-week low?
Unlimited trading at just
Rs. 199*